Ameriprise Financial Inc Amneal Pharmaceuticals, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 1,588,368 shares of AMRX stock, worth $14.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,588,368

Previous 10,724 14711.34%

Holding current value

$14.3 Million

Previous $68,000 19333.82%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$6.42 - $8.83 $10.1 Million - $13.9 Million	1,577,644 Added 14711.34%	1,588,368 $13.2 Million
Q2 2024 Aug 14, 2024	SELL	$5.36 - $7.11 $2,063 - $2,737	-385 Reduced 3.47%	10,724 $68,000
Q1 2024 May 15, 2024	SELL	$5.24 - $6.34 $371,678 - $449,702	-70,931 Reduced 86.46%	11,109 $67,000
Q4 2023 Feb 14, 2024	BUY	$3.36 - $6.21 $43,152 - $79,755	12,843 Added 18.56%	82,040 $497,000
Q3 2023 Nov 14, 2023	BUY	$2.76 - $4.59 $145,388 - $241,787	52,677 Added 318.87%	69,197 $292,000
Q2 2023 Aug 14, 2023	SELL	$1.33 - $3.1 $135,242 - $315,226	-101,686 Reduced 86.02%	16,520 $51,000
Q1 2023 May 15, 2023	BUY	$1.27 - $2.7 $40,514 - $86,132	31,901 Added 36.96%	118,206 $164,000
Q4 2022 Feb 14, 2023	BUY	$1.96 - $2.61 $52,627 - $70,081	26,851 Added 45.16%	86,305 $171,000
Q3 2022 Nov 14, 2022	BUY	$2.02 - $3.62 $66,260 - $118,743	32,802 Added 123.08%	59,454 $120,000
Q2 2022 Aug 15, 2022	BUY	$3.01 - $4.46 $28,402 - $42,084	9,436 Added 54.81%	26,652 $85,000
Q1 2022 May 16, 2022	BUY	$3.9 - $4.89 $452 - $567	116 Added 0.68%	17,216 $72,000
Q4 2021 Feb 14, 2022	SELL	$3.95 - $5.85 $3,357 - $4,972	-850 Reduced 4.74%	17,100 $82,000
Q3 2021 Nov 15, 2021	BUY	$4.31 - $5.64 $430 - $564	100 Added 0.56%	17,950 $96,000
Q2 2021 Aug 16, 2021	BUY	$5.12 - $6.82 $91,392 - $121,737	17,850 New	17,850 $91,000
Q4 2020 Feb 12, 2021	SELL	$3.95 - $5.42 $300,733 - $412,651	-76,135 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$3.54 - $5.27 $98,500 - $146,637	27,825 Added 57.6%	76,135 $296,000
Q2 2020 Aug 14, 2020	SELL	$2.87 - $5.46 $200,986 - $382,363	-70,030 Reduced 59.18%	48,310 $230,000
Q1 2020 May 15, 2020	BUY	$2.46 - $5.35 $291,116 - $633,119	118,340 New	118,340 $413,000
Q3 2019 Nov 14, 2019	SELL	$2.29 - $7.1 $2.26 Million - $7.01 Million	-987,608 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$6.44 - $14.29 $5.4 Million - $12 Million	-838,677 Reduced 45.92%	987,608 $7.08 Million
Q1 2019 May 15, 2019	SELL	$11.87 - $14.84 $372,528 - $465,738	-31,384 Reduced 1.69%	1,826,285 $25.9 Million
Q4 2018 Feb 14, 2019	SELL	$13.09 - $21.49 $1.07 Million - $1.75 Million	-81,430 Reduced 4.2%	1,857,669 $25.1 Million
Q3 2018 Nov 14, 2018	SELL	$16.4 - $24.27 $18.1 Million - $26.9 Million	-1,106,394 Reduced 36.33%	1,939,099 $43 Million
Q2 2018 Aug 14, 2018	BUY	$13.95 - $20.2 $42.5 Million - $61.5 Million	3,045,493 New	3,045,493 $50 Million

Others Institutions Holding AMRX

# of Institutions

185

Shares Held

141M

Call Options Held

57K

Put Options Held

49K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.36B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Amneal Pharmaceuticals, Inc. Transaction History